|
overrides may be available. The message format must comply with | National Council for Prescription Drug Programs standards. |
|
| | 5. By October 1, 2005, the department shall minimize the | burden on providers of submitting duplicative medical records on | behalf of a MaineCare member. In order to reduce the submission | of duplicate information, the department shall work to provide | notice to providers of the types of documentation required and to | create a prior authorization file for each member. |
|
| | 6. The department shall provide prompt notice of changes to | the preferred drug list through posting on its website, its group | electronic mailings regarding pharmacy issues and notices to | provider organizations. |
|
| | 7. The department shall arrange to allow submission of the | prior authorization form and other required documentation as an | e-mail attachment when such submissions are feasible. |
|
| | 8. By January 15, 2006, the department shall amend its rules | regarding the drug utilization review committee under the | MaineCare Benefits Manual, chapter II, section 80.01-13 to | establish conflict-of-interest standards for members of the | committee. |
|
| | 9. The department shall consult with the MaineCare Advisory | Committee on the design of future studies related to pharmacy | prior authorization, including a survey of MaineCare members. | The department shall report to the Joint Standing Committee on | Health and Human Services by February 1, 2006 on its progress in | implementing this subsection. |
|
|